ReviewFrontiers in cardiovascular medicine2023
Artificial intelligence in coronary computed tomography angiography: Demands and solutions from a clinical perspective.
Review in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Application of artificial intelligence in non-invasive cardiovascular imaging for coronary artery disease: a systematic review and meta-analysis.Frontiers in cardiovascular medicine · 2025Pooled it
- Role of artificial intelligence in developing predictive models for major adverse cardiovascular outcomes using CCTA adipose tissue characteristics: a systematic review and meta-analysis.European heart journal. Digital health · 2026Review
- Article
- Explainable and Trustworthy Artificial Intelligence in Cardiology: A Narrative Review of Clinical Applications, Operational Integration, and Future Directions.Journal of clinical medicine · 2026Review
- Motion compensated reconstruction improves image quality and interpretability of dual-layer coronary CT angiography.European radiology · 2026Article
- Cardiovascular CT in Bicuspid Aortic Valve Disease: A State-of-the-Art Narrative Review of Advances, Clinical Integration, and Future Directions.Journal of clinical medicine · 2026Review
- Artificial Intelligence in Adult Cardiovascular Medicine and Surgery: Real-World Deployments and Outcomes.Journal of personalized medicine · 2026Review
- Deciphering age- and sex-specific patterns of coronary artery atherosclerosis from a large Chinese cohort.Nature communications · 2025Article
- Applications of Artificial Intelligence in Transcatheter Aortic Valve Replacement: A Review of the Literature.Life (Basel, Switzerland) · 2025Review
- Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis.The international journal of cardiovascular imaging · 2025Review
- Artificial intelligence in coronary artery calcification scoring: Current progress and future directions.Global cardiology science & practice · 2025Review
- Review
- The Role of Coronary Computed Tomography Angiography in the Diagnosis, Risk Stratification, and Management of Patients with Diabetes and Chest Pain.Reviews in cardiovascular medicine · 2024Review
- Moving towards a uniform diagnosis of coronary artery disease on coronary CTA : Coronary Artery Disease-Reporting and Data System 2.0.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024Review
- Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature.Atherosclerosis · 2024Review
- Revolutionising Acute Cardiac Care With Artificial Intelligence: Opportunities and Challenges.The Canadian journal of cardiology · 2024Review
- Computed Tomography Evaluation of Coronary Atherosclerosis: The Road Travelled, and What Lies Ahead.Diagnostics (Basel, Switzerland) · 2024Review
- Artificial intelligence-assisted measurements of coronary computed tomography angiography parameters such as stenosis, flow reserve, and fat attenuation for predicting major adverse cardiac events in patients with coronary arterial disease.Biomolecules & biomedicine · 2024Article
- Multimodal Cardiac Imaging Revisited by Artificial Intelligence: An Innovative Way of Assessment or Just an Aid?Cureus · 2024Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Coronary computed tomography angiography (CCTA) is increasingly the cornerstone in the management of patients with chronic coronary syndromes. This fact is reflected by current guidelines, which show a fundamental shift towards non-invasive imaging - especially CCTA. The guidelines for acute and stable coronary artery disease (CAD) of the European Society of Cardiology from 2019 and 2020 emphasize this shift. However, to fulfill this new role, a broader availability in adjunct with increased robustness of data acquisition and speed of data reporting of CCTA is needed. Artificial intelligence (AI) has made enormous progress for all imaging methodologies concerning (semi)-automatic tools for data acquisition and data post-processing, with outreach toward decision support systems. Besides onco- and neuroimaging, cardiac imaging is one of the main areas of application. Most current AI developments in the scenario of cardiac imaging are related to data postprocessing. However, AI applications (including radiomics) for CCTA also should enclose data acquisition (especially the fact of dose reduction) and data interpretation (presence and extent of CAD). The main effort will be to integrate these AI-driven processes into the clinical workflow, and to combine imaging data/results with further clinical data, thus - beyond the diagnosis of CAD- enabling prediction and forecast of morbidity and mortality. Furthermore, data fusing for therapy planning (e.g., invasive angiography/TAVI planning) will be warranted. The aim of this review is to present a holistic overview of AI applications in CCTA (including radiomics) under the umbrella of clinical workflows and clinical decision-making. The review first summarizes and analyzes applications for the main role of CCTA, i.e., to non-invasively rule out stable coronary artery disease. In the second step, AI applications for additional diagnostic purposes, i.e., to improve diagnostic power (CAC = coronary artery classifications), improve differential diagnosis (CT-FFR and CT perfusion), and finally improve prognosis (again CAC plus epi- and pericardial fat analysis) are reviewed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.